A functional interrelation between nitric oxide (NO), the endothelial-derived vasodilating factor, and endothe lin 1 (ET-l), the potent vasoconstrictive peptide, was investi gated in microvascular endothelium of human brain. Nor-l dose-dependently decreased the ET-l-stimulated mobilization of Ca 2 +. This response was mimicked with cGMP and abro gated by inhibitors of guanylyl cyclase or cGMP-dependent protein kinase G, These findings indicate that NO and ET-I
Endothelin 1 (ET -1), a 21-amino acid peptide, and nitric oxide (NO), a simple gas are produced by vascular endothelium among other cells (Bacic et aI., 1992; Du rieu-Trautmann et aI., 1993; Masaki, 1994; Yanagisawa et aI., 1988) . Each of these agents exerts a variety of biological effects affecting many physiologic functions (MacCumber et aI., 1990; Masaki, 1994; Moncada et aI., 1991; Walsh et aI., 1995) . Endothelin 1 and NO, origi nally established as potent vasoactive substances, may influence regional and systemic vascular tone as well as blood flow through their antagonistic properties (vaso constrictive and vasodilatory, respectively) (Bakker et aI., 1997; Gellai et aI., 1997; MacCumber et aI., 1990;  interactions involved in modulation of intracellular Ca 2 + are mediated by cGMP/protein kinase G. In addition, Nor-l mediated effects were associated with rearrangements of cyto skeleton F-actin filaments. The results suggest mechanisms by which NO-ET -1 interactions may contribute to regulation of microvascular function. Key Words: Actin-Brain endothelial cells-Ca 2 + Mobilization-cGMP-Endothelin-Nitric oxide. Masaki, 1994; Moncada et aI., 1991; Thorin et aI., 1998) . Hypothetically, these endothelium-mediated processes require a potentially intimate interaction between these two substances at the level of cellular secretion and/or receptors, leading to alteration of contractile elements of the cellular cytoskeleton. Previously, ET -1 was shown to induce NO secretion that in turn reduces the production of ET -1 in endothelium (Boulanger and Luscher, 1990; Saijonmaa et aI., 1990) . Other studies demonstrate that the poorly dissociable binding of ET -1 to its receptor could be affected by a single exposure to NO (Goligor sky et aI., 1994; Spatz et aI., 1997 b) . These findings have contributed to the understanding of mechanisms entailed in the regulation of blood flow. However, this response is insufficient to explain a possible rapid interactive event between ET-l and NO that could be instrumental in maintaining vascular and microvascular tone. Numerous investigations suggest that alterations of in tracellular Ca 2 + are involved in vascular responses to various neuronal and humoral factors (Cornwell and Lin coln, 1989; Rasmussen, 1983; Walsh et aI., 1995) . The mechanisms responsible for the activity of these agents have been studied mainly in smooth muscle derived from peripheral vessels. It also has been shown that the ET I-stimulated intracellular Ca 2 + in platelets, polymorpho nuclear leukocytes, smooth muscle, and Chinese hamster ovary cells (CHO-ET) transfected with ETA receptor cDNA can be influenced by NO (Farre et aI., 1991; Go ligorsky et aI., 1994; Okishio et aI., 1992) . In addition, reports indicate that a factor involved in the signal path way of vasoactive agent-induced elevations of cGMP or cAMP (i.e., vasodilator-stimulated phosphoprotein) is associated with cytoskeletal components (i.e., F-actin) (Reinhard et a!., 1992) . Actin is one of the main cyto skeletal proteins that mediates many processes essential to maintain cellular structure and function (e.g., mem brane polarity, tight junctions, cellular adhesions, and signal transduction). Ischemic cell injury may not only affect events controlled by ET -1 and NO, but also by cytoskeletal actin (e.g., postischemic hypoperfusion, cellular permeability) (see review, Molitoris et a!., 1997; Spatz et aI., 1996) . However, little information is available concerning the function of the cerebral microvasculature, particularly regarding a relationship between ET-I and NO effects on cellular Ca 2 + and cy toskeletal architecture. Thus, we investigated the effect of NO on ET-l -induced changes in both intracellular Ca 2 + and F-actin in endothelium derived from microves sels of human brain (HBMEC). This report demonstrates that NO reduces the endothelial ET-I -stimulated mobi lization of intracellular Ca 2 +; this effect is mediated by a cGMP-dependent mechanism through activation of cGMP-dependent protein kinase G (PKG). The rapid an tagonistic effect of NO on the ET -I-stimulated mobili zation of intracellular Ca 2 + is associated with re organization of the endothelial cytoskeletal F-actin fila ments. These findings implicate the potential involvement of HBMEC in the control of microvascular function (i.e., tone, cerebral blood flow, and blood-brain barrier properties). 
MATERIALS AND METHODS

Chemicals and reagents
Cell culture
The technique used for preparing HBMEC was previously described (Spatz et aI., 1997a) . Briefly, the cultured microvas cular endothelium was dissociated from microvessels of human brain surgically removed for the treatment of idiopathic epi lepsy. For this study, HBMEC (from six cell lines [each derived from a different brain], passage 7 to IS) were grown to con fluence on I % gelatin-coated 24-well plates at 37°C in humidi fied atmosphere of S% CO 2 /air for 48 hours. The purity of the endothelial cell cultures was about 98%, as determined by posi tive immunostaining for von Willebrand (factor VIII)-related antigen and incorporation of acetylated low-density lipoprotein, as well as negative staining for glial cell (GFAP, galactocere broside, and ED-2). musele cell, and pericyte (a-actin and tropomyosin, respectively) markers.
Measurements of intracellular calcium
The HBMEC were grown for 48 hours on 24-well plates and washed with buffer composed of NaCI (1 37 
RESULTS
Effect of endothelin 1 on intracellular
Ca 2 + mobilization
The ET-l dose-dependently increased intracellular Ca 2 + (Fig. lA) . The maximal effect was reached at 100 nmol/L ET -1; the estimated ECso was 20 nmollL ET-l. No variations in these parameters were observed among the various HBMEC passages (7 to 15) used for these experiments. The selective ETA-receptor antagonist (BQ 123 or Ro 61-1790), but not the selective ETB-receptor antagonist, (BQ788) almost completely abolished the ET -I -induced Ca 2 + mobilization. The selective inhibitor of phospholipase C (U-73I 22; 10 J.,LmollL) also inhibited (60.3%) the ET-I-stimulated Ca2+ mobilization. In con-trast, NG-Nitro-L-arginine methyl ester (L-NAME), the inhibitor of nitric oxide synthetase, doubled the ET -1stimulated intracellular Ca 2 + in HBMEC (data not shown).
Effect of nitric oxide on ET-l-induced intracellular Ca 2 +
To assess potential interaction between endogenous or exogenous NO and ET-l on Ca 2 + mobilization, HBMEC were pretreated with L-arginine in the presence or ab sence of L-NAME (40 minutes). L-Arginine decreased the Ca2+ mobilization stimulated by 20 nmollL ET-l (Fig. IB) . This effect was reversed by L-NAME. In ad dition, pretreatment (1 minute) with the NO donor, NOR-I, resulted in the dose-dependent reduction of ET I-induced Ca 2 + mobilization (Fig. 1 C) .
FIG. 1. Characterization of intracel lular Ca2+ response in endothelium derived from microvessels of human brain (HBMEC) to endothelin 1 (ET-1) alone or in the presence of nitric oxide donors. All HBMEC grown on 24-well plates and processed as in dicated in the methods section were 20 50 100 exposed to ET-l alone for 30 sec onds or to either NOR-l for 60 sec onds or 8-bromo-cGMP for 100 sec onds before addition of ET-l for 30 seconds. The HBMEC treated with L arginine in the presence or absence of L-NAME were incubated for 40 minutes before addition of ET-l for and modulated by NOR-l (50 J,JmoI/L); 'significant difference from ET-l alone, P < 0.01 by ANOVA with Fisher's PLSD; tindicates significant difference from ET-l plus NOR-l (50 J,JmoI/L), P < 0.01 by ANOVA with Fisher's PLSD.
Effect of cGMP on endothelin I-induced intracellular Ca 2 +
To examine the possible role of cGMP on NO media tion of the ET-l-stimulated mobilization of Ca 2 +, HB MEC were pretreated (100 seconds) with membrane per meable 8-bromo-cGMP. Treatment with 8-bromo-cGMP dose-dependently prevented ET -I-induced increases in intracellular Ca 2 + (Fig. ID) . These data suggest that the observed effects of NO on ET-l-induced Ca 2 + mobili zation involve cGMP. These results indicate that NO or cGMP alteration of ET-l -stimulated Ca 2 + mobilization in HBMEC are me diated through the soluble guanylyl cyclase-cGMP dependent protein kinase system.
Effect of endothelin I and nitric oxide on F -actin filaments
The HBMEC contain delicate longitudinal F-actin filaments, which are most pronounced at the periphery ( Fig. 2A) . These filaments are rarified and interposed by occasional granules after exposure to 100 fLmollL NOR-l (Fig. 2C) . In contrast, treatment of HBMEC with 50 nmol/L of ET-l increased the thickness and promi nence of the longitudinal F-actin filaments (Fig. 2B) . This ET-l-induced effect was altered by pretreatment with 100 fLmol/L NOR-I , as characterized by the dis connected short, thin, and granular filaments (Fig. 2D) . Similar responses of F-actin filaments were observed at 20 nmollL of ET-l and 50 fLmollL of NOR-l (data not shown).
DISCUSSION
The results of this study clearly indicate that ET -I , which induces Ca 2 + mobilization in HBMEC through activation of ETA receptor coupled to PLC, can interact with endogenous or exogenous NO. This event was manifested by two observations: 1) NO reduction of ET I-evoked transient stimulation of Ca 2 + mobilization, which is mediated by cGMP signal transduction path way, and 2) alteration of cytoskeleton (F-actin fila ments). The interference by NO on ET -I -induced Ca 2 + changes was reported in vascular smooth muscle, poly morphonuclear leukocytes, and Chinese hamster ovary 1999 ET-l (Farre et aI., 1991; Goligorsky et aI., 1994; Okishio et aI., 1992) . However, in some of these cases, the effects of the interaction between ET-l and NO (e.g., Ca 2 + re duction, vasodilation) did not involve the activation of soluble guanylyl cyclase and/or PKG (Goligorsky et aI., 1994) . The data presented here unequivocally indicate that the signal responsible for the observed decrease of ET-l-induced Ca 2 + mobilization involves soluble gua nylyJ cyclase, the first step of the NO signal transduction pathway (Cornwell and Lincoln, 1989; Moncada et aI., 1991; Riesco et aI., 1993; Schmidt et aI., 1993) . This observation is evidenced by the fact that ODQ, the se lective inhibitor of this enzyme, prevented the NO mediated decrease of ET -I -induced Ca 2 + mobilization. The fact that 8-bromo-cyclic GMP mimicked the NO activity is in agreement with this contention and with the reported subsequent rise in cGMP induced by NO. In addition, the prevention of NO-induced reduction of ET I-evoked Ca 2 + mobilization by Rp-8-pCPT-cGMPS (in hibitor of PKG) and the ineffectiveness of other protein kinase inhibitors (PKC, PKA) indicate that this effect is mediated by PKG, a prominent member of NO-signal transduction pathway (Cornwell and Lincoln, 1989; Moncada et al., 1991; Pryzwansky et aI., 1995; Schmidt et aI., 1993; Walsh et aI., 1995) .
Based on these results alone, we cannot ascertain whether the NO-mediated abrogation of ET-l -induced increase in intracellular Ca2+ takes place on the level of ETA receptor and/or postreceptor pathway. Studies in other cells show that suppressors of Ca 2 + mobilization (e.g., NO donors, atriopeptin) may act on the level of a given agonist receptor (e.g., thrombin [Arg]-vasopressin or ET-l) or on postreceptor pathway (e.g., G protein, inositol-l ,4,5-triphosphate (IP3) metabolism, IP3 recep tor, and/or ryanodine receptor, Ca 2 + channels) (Goligor sky et aI., 1994; Rasmussen, 1983; Spatz et aI., 1997b) . Previous studies demonstrate that exposure of HBMEC to NO donors for 2 to 4 hours modified ET-l receptor binding sites and ET-}-stimulated IP3 formation (Spatz et ai, 1997b;  and unpublished data). However, prelimi nary investigations of NO inhibitory sites of ET -\ stimulated Ca 2 + mobilization in HBMEC support local ization along the distal pathway of ETA receptors. Nev ertheless, it remains to be clarified whether the same brief NO treatment that reduced ET-l-stimulated Ca 2 + mobilization also can alter ET -1 binding.
The findings regarding ET -1-and/or NO-induced changes in the pattern of cytoskeleton F-actin filaments and their association with alterations in Ca 2 + mobiliza tion are interesting. The involvement of cytoskeleton proteins in a variety of cellular functions (e.g., locomo tion and architectural organization of the cells) has been the subject of numerous studies for the last decade (see review, Molitoris et aI., 1997) . The observed rapid phos phorylation of the cytoskeleton-associated protein impli-FIG. 2. Response of F-actin cytoskeleton in HBMEC to ET-1 and NOR-1. The HBMEC grown on glass coverslips and processed as indicated in the methods were exposed to medium alone (A), ET-1 (50 nmol/L) for 30 seconds (8), NOR-1 (100 iJmol/L) for 60 seconds (C), or NOR-1 (100 iJmol/L) for 60 seconds, followed by ET-1 (50 nmol/L) for 30 seconds (0). All cells were stained with phalloidin and examined with Zeiss Axioplan fluorescence microscopy (magnification x63). (A) Control HBMEC display delicate (thin) longitudinal F-actin filaments, which are more pronounced at the periphery. (B) The HBMEC exposed to ET-1 for 30 seconds contain numerous compacted F-actin filaments, which are distributed throughout the entire cytoplasm. These filaments are more pronounced than those seen in control (A). (C) The HBMEC exposed to NOR-1 display rarified longitudinal filaments interposed by occasional granular-like filaments of F-actin.
(D) The HBMEC pretreated with NOR-1 and exposed to ET-1 show delicate filaments that are thinner than those exposed to ET-1 alone (B) and are similar to those observed in (A) and (C).
cates the responsible protein kinases in the regulation of cytoskeleton function. For example, vasodilator stimulated phosphoprotein activity was shown to corre late with vasodilator-induced (e.g., prostaglandin E, prostacyclin 1 2 , or sodium nitroprusside) inhibition of platelet activation mediated by cAMP-and cGMP dependent protein kinase. This phosphoprotein co localized with F-actin in platelets, fi broblasts, and smooth muscle cells (Reinhard et aI., 1992) . Co localization of cGMP-dependent protein kinase with in termediate filament protein vimentin also was demon strated in smooth muscle (MacMillan-Crow and Lincoln, 1994; Pryzwansky et aI., 1995) . These reports, together with the findings reported here, strongly support the in volvement of protein kinase G in F-actin rearrangements induced by the interaction between ET-l and NO (dia gram, Fig. 3 ). The participation of other regulatory pro teins, as well as yet unidentified factors, cannot be ex cluded. For example, rho, which is a member of small GTPases and the distant relatives of G proteins, was reported to affect actin-myosin filaments and contraction (see review, Hall, 1998) . Also, contractile cytoskeletal stimulatory proteins (CSP; Fig. 3 ) represent a hypotheti cal possibility borne from observations concerning the relationship between vasodilators and stimulation of va sodilatory proteins, such as vasodilator-stimulated phos-
